Alembic`s Generic Bromfenac Receives Approval in the U.S.
Lupin gets USFDA nod for Bromfenac Ophthalmic Solution
Eugia's Generic Bromfenac Receives Approval in the U.S.
Enforcement Report for Week of February 20, 2019
Enforcement Report - Week of February 6, 2019
Prolensa (Bromfenac) : Senju Pharmaceutical, Bausch & Lomb Pharma vs. Amneal Pharmaceuticals
In the ‘Arena of Valour,’ a popular online game, the character Ilumia is a wizard endowed with powers to inflict damage and protect others. Victory is assured with Ilumia by your side, claim gaming platforms.
Prolensa®(bromfenac): Senju Pharmaceutical v. Amneal Pharmaceuticals
The Food and Drug Administration has issued tentative approval to Perrigo for its generic of Bausch & Lomb’s Prolensa (bromfenac ophthalmic solution, 0.07%). The product is indicated to treat post-operative inflammation and reduce ocular pain in cataract surgery recipients.
Sun PharmaBSE -0.36 %, Dr. Reddy’s, GlenmarkBSE -0.33 %, Zydus Cadila, AurobindoBSE 1.03 % and their ilk are embracing a new life. Deploying investments to bolster indigenous research and lapping up late clinical stage drugs or new brands is heralding a seismic shift from churning copies of drugs to the daunting world of innovative or differentiated brands.